Adler BJ, Kaushansky K, Rubin CT Obesity-driven disruption of haematopoiesis and the bone marrow niche. Nat Rev Endocrinol. 2014 Dec;10(12):737-48. doi: 10.1038/nrendo.2014.169. Epub 2014 Oct 14. Review.
Baptista LS, Silva KR, Borojevic R Obesity and weight loss could alter the properties of adipose stem cells? World J Stem Cells. 2015 Jan 26;7(1):165-73. doi: 10.4252/wjsc.v7.i1.165. Review.
Benites BD, Gilli SC, Saad ST Obesity and inflammation and the effect on the hematopoietic system. Rev Bras Hematol Hemoter. 2014 Mar;36(2):147-51. doi: 10.5581/1516-8484.20140032. Review.
Cawley J, Meyerhoefer C The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012 Jan;31(1):219-30. doi: 10.1016/j.jhealeco.2011.10.003. Epub 2011 Oct 20.
El-Tantawy WH, Haleem EN Therapeutic effects of stem cell on hyperglycemia, hyperlipidemia, and oxidative stress in alloxan-treated rats. Mol Cell Biochem. 2014 Jun;391(1-2):193-200. doi: 10.1007/s11010-014-2002-x. Epub 2014 Mar 7.
Finkelstein EA, Trogdon JG, Cohen JW, Dietz W Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009 Sep-Oct;28(5):w822-31. doi: 10.1377/hlthaff.28.5.w822. Epub 2009 Jul 27.
Forsythe LK, Wallace JM, Livingstone MB Obesity and inflammation: the effects of weight loss. Nutr Res Rev. 2008 Dec;21(2):117-33. doi: 10.1017/S0954422408138732. Review.
Jialal I, Devaraj S, Singh U, Huet BA Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis. 2010 Jul;211(1):297-302. doi: 10.1016/
Kahn SE, Hull RL, Utzschneider KM Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006 Dec 14;444(7121):840-6. Review.
Kashyap SR, Gatmaitan P, Brethauer S, Schauer P Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med. 2010 Jul;77(7):468-76. doi: 10.3949/ccjm.77a.09135. Review.
Keidar A Bariatric surgery for type 2 diabetes reversal: the risks. Diabetes Care. 2011 May;34 Suppl 2:S361-266. doi: 10.2337/dc11-s254.
Kizil C, Kyritsis N, Brand M Effects of inflammation on stem cells: together they strive? EMBO Rep. 2015 Apr;16(4):416-26. doi: 10.15252/embr.201439702. Epub 2015 Mar 4. Review.
Mathieu P, Lemieux I, Després JP Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther. 2010 Apr;87(4):407-16. doi: 10.1038/clpt.2009.311. Epub 2010 Mar 3. Review.
Mulla CM, Middelbeek RJW, Patti ME Mechanisms of weight loss and improved metabolism following bariatric surgery. Ann N Y Acad Sci. 2018 Jan;1411(1):53-64. doi: 10.1111/nyas.13409. Epub 2017 Sep 3. Review.
Oh J, Lee YD, Wagers AJ Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med. 2014 Aug;20(8):870-80. doi: 10.1038/nm.3651. Review.
Ponce J, DeMaria EJ, Nguyen NT, Hutter M, Sudan R, Morton JM American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis. 2016 Nov;12(9):1637-1639. doi: 10.1016/j.soard.2016.08.488. Epub 2016 Aug 26. Review.
Ponce J, Nguyen NT, Hutter M, Sudan R, Morton JM American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in the United States, 2011-2014. Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1199-200. doi: 10.1016/j.soard.2015.08.496. Epub 2015 Aug 12. Review.
Stirban AO, Tschoepe D Cardiovascular complications in diabetes: targets and interventions. Diabetes Care. 2008 Feb;31 Suppl 2:S215-21. doi: 10.2337/dc08-s257. Review.
Wu CL, Diekman BO, Jain D, Guilak F Diet-induced obesity alters the differentiation potential of stem cells isolated from bone marrow, adipose tissue and infrapatellar fat pad: the effects of free fatty acids. Int J Obes (Lond). 2013 Aug;37(8):1079-87. doi: 10.1038/ijo.2012.171. Epub 2012 Nov 20.
Impact of Bariatric Surgery on Circulating Inflammatory and Pro-vascular Progenitor Cell Populations.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.